ClinConnect ClinConnect Logo
Search / Trial NCT05602272

Respiratory and Hemodynamic Implications of Endoscopic Myotomy of the Esophagus and Stomach

Launched by CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS · Oct 27, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Anesthesia Pneumoperitoneum Poem Gpoem

ClinConnect Summary

This clinical trial is studying the effects of certain endoscopic treatments, specifically peroral endoscopic myotomy (POEM) and gastric peroral endoscopic myotomy (GPOEM), on breathing and blood pressure in patients with conditions like esophageal achalasia and gastroparesis. The researchers want to understand if there are specific factors that could predict complications during general anesthesia and how changes in pressure within the abdomen might affect a patient’s breathing and blood flow during these procedures.

If you are at least 18 years old and classified as having a low to moderate risk for anesthesia (ASA classification 1 to 3), you may be eligible to participate. Participants will receive standard care for their treatment and will not have to follow any special rules beyond what is usual for this procedure. It's important to note that individuals who have difficulty following study procedures due to language or mental health issues may not be able to take part in this trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Completed and signed consent form (consent form attached)
  • Age ≥ 18 years old
  • Anesthetic risk classification according to ASA, from 1 to 3
  • Patients summoned for POEM or GPOEM type endoscopy treatment
  • Exclusion Criteria:
  • - Inability to follow study procedures, eg. due to language problems, psychological disorders, dementia, etc. of the participant

About Centre Hospitalier Universitaire Vaudois

The Centre Hospitalier Universitaire Vaudois (CHUV) is a leading academic medical center located in Lausanne, Switzerland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUV plays a pivotal role in translating scientific discoveries into transformative therapies, enhancing patient care across a diverse range of medical disciplines. With a multidisciplinary team of experts and state-of-the-art facilities, CHUV is dedicated to fostering collaboration and delivering high-quality evidence that informs clinical practice and policy.

Locations

Lausanne, Vaud, Switzerland

Patients applied

0 patients applied

Trial Officials

Madeleine Chollet-Rivier

Principal Investigator

University of Lausanne Hospitals

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials